NCT06004934 A Study to Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic Impairment Status COMPLETED Phase PHASE1
NCT05995691 Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants Status COMPLETED Phase PHASE1
NCT05988034 A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants Status COMPLETED Phase PHASE1
NCT05988021 A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168 Status COMPLETED Phase PHASE1
NCT05988008 A Study of CCX168 in Japanese and Caucasian Healthy Adult Males Status COMPLETED Phase PHASE1
NCT05984251 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05975073 A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05972551 Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05920356 A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) Status RECRUITING Phase PHASE3
NCT05913115 A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer Status COMPLETED Phase PHASE1
NCT05909852 A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05909761 Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy Status RECRUITING Phase N/A
NCT05907122 A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma Status COMPLETED Phase PHASE3
NCT05899816 A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) Status COMPLETED Phase PHASE3
NCT05891119 Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase EARLY_PHASE1
NCT05885607 Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05885451 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants Status COMPLETED Phase PHASE1
NCT05882877 A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Status TERMINATED Phase PHASE3
NCT05873907 A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants Status COMPLETED Phase PHASE1